Cite
van Haaps TF, Collard D, van Osch FHM, et al. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study. Thromb Res. 2021;208:35-38doi: 10.1016/j.thromres.2021.10.006.
van Haaps, T. F., Collard, D., van Osch, F. H. M., Middeldorp, S., Coppens, M., de Kruif, M. D., Vlot, E. A., Douma, R. A., Ten Cate, H., Juffermans, N. P., Gritters, N., Vlaar, A. P., Reidinga, A. C., Heuvelmans, M. A., Oudkerk, M., Büller, H. R., van den Bergh, J. P. W., Maas, A., Ten Wolde, M., Simsek, S., Beudel, M., van Es, N. (2021). Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study. Thrombosis research, 20835-38. https://doi.org/10.1016/j.thromres.2021.10.006
van Haaps, Thijs F, et al. "Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study." Thrombosis research vol. 208 (2021): 35-38. doi: https://doi.org/10.1016/j.thromres.2021.10.006
van Haaps TF, Collard D, van Osch FHM, Middeldorp S, Coppens M, de Kruif MD, Vlot EA, Douma RA, Ten Cate H, Juffermans NP, Gritters N, Vlaar AP, Reidinga AC, Heuvelmans MA, Oudkerk M, Büller HR, van den Bergh JPW, Maas A, Ten Wolde M, Simsek S, Beudel M, van Es N. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study. Thromb Res. 2021 Oct 15;208:35-38. doi: 10.1016/j.thromres.2021.10.006. Epub 2021 Oct 15. PMID: 34688100; PMCID: PMC8518131.
Copy
Download .nbib